Gene Query: LAMC1

Dataset Description Geneva Score
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 211.15
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 74.33
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 67.58
hnRNP C is a key regulator of protein synthesis in mitosis 61.85
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 59.9
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 56.79
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 55.53
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 54.34
Transcriptome analysis of kidney organoids 52.71
Global expression profiles in cardiac progenitor cells generated by ISX-9 45.28
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 45.28
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 45.09
Spliceosomal disruption of the non-canonical BAF complex in cancer 44.37
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 43.68
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 40.81
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 40.74
MCF-7 as a model for functional analysis of breast cancer risk variants 40.73
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 40.49
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 39.46
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 38.94
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 38.94
Energy Metabolism during Anchorage-Independence 38.78
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 37.18
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 34.77
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 34.77
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 34.76
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 34.44
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 33.63
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 33.63
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 32.84
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 32.35
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 31.74
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 31.74
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 31.39
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 31.17
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 30.6
Control of prostate tumour growth by the long non-coding RNA GHSROS 30.59
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 29.7
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 29.51
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 29.07
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 27.49
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 27.23
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 26.7
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 26.17
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 25.65
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 25.55
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 25.06
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 24.81
High-throughput sequencing of PROMPT-enriched samples. 24.25
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 24.2
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 23.69
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 22.96
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 22.92
Pharmacologic inhibition of STAT5 in AML 22.71
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 22.68
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 22.68
Gene expression changes after LOC550643 silencing 22.58
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 22.51
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 22.51
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 22.45
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 21.92
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 21.83
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 21.54
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 20.63
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 20.63
RNA-Seq analysis of breast cancer cells after shikonin treatment 20.34
JAK dependent survival of ALK- ALCL 20.32
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 20.24
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 19.83
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 19.59
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 19.56
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 19.55
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 19.24
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 19.18
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 19.15
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 19.06
Regulation of highly expressed hCINAP on translatome 18.95
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 18.92
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 18.53
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 18.46
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 18.35
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 18.28
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 18.25
Sensing self and nonself circular RNAs 18.25
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 18.2
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 18.18
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 18.15
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 18.15
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 17.79
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 17.73
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 17.66
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 17.66
mRNA expression in human DAOY cells 17.51
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 17.46
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 17.35
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 17.2
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 17.2
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 16.98
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 16.89
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 16.7
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 16.66
Role of XRN2 ribonucleolytic activity in RNA metabolism 16.66
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 16.64
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 16.59
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 16.31
ChIP-seq and RNA-seq from human lymphoma cell lines 16.3
RNA-seq data from human lymphoma cell lines 16.3
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 16.29
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 15.98
MEIS1 regulates hematopoiesis in hPSCs 15.84
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 15.82
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 15.66
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 15.63
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 15.49
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 15.37
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 15.26
Epigenomic landscape during organ formation in human early embryos 15.21
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 15.2
Accurate annotation of human protein-coding small open reading frames 15.18
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 15.03
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 14.99
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 14.85
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 14.8
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 14.66
Transcriptional profiles of normal human mature B cells 14.53
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 14.48
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 14.48
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 14.47
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 14.47
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 14.36
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 14.35
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 14.35
DJ-1 is dispensable for human stem cell homeostasis 14.34
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 14.14
3’ Uridylation Expands miRNA Target Repertoire 14.08
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 14.05
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 14.0
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 13.96
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 13.92
Modeling Familial Cancer with iPSC Approaches 13.9
Zika virus directly infects human peripheral neurons and induces cell death 13.83
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 13.78
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.77
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 13.68
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 13.66
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 13.57
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 13.53
RNA-seq analyses of human prostate cancer cells 13.46
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 13.45
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 13.44
RNA transcriptome analysis during HSV-1 infection 13.39
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 13.36
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 13.19
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 13.11
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 13.1
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 13.08
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.07
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 13.01
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 12.98
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 12.85
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 12.79
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 12.73
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 12.7
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 12.63
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 12.61
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 12.6
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 12.6
HNF1A deficiency impairs β-cell fate, granule maturation and function 12.58
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 12.57
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 12.5
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 12.44
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.42
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.42
The interplay between SOX4 and SMAD3 in the context of breast cancer 12.38
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 12.35
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 12.35
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 12.35
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.33
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 12.32
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 12.32
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 12.32
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 12.31
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 12.24
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 12.19
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 12.03
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 12.0
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 11.97
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 11.97
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 11.96
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 11.95
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 11.92
Postnatal lipids drive hepatocyte maturation 11.9
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 11.84
Genome wide expression change by RNF168 knocking down in MCF-7 cells 11.82
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 11.78
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 11.77
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 11.77
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 11.63
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 11.63
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 11.59
Gene induction by the USP6 oncogene in response to interferon 11.55
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 11.54
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 11.52
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 11.47
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 11.46
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 11.46
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 11.31
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 11.31
Identification of transcription start sites for human A549 cell line using ReCappable-seq 11.22
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 11.15
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 11.08
Exploring the RNA landscape of endothelial exosomes 11.01
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 10.98
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.93
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 10.93
Survival of pancreatic cancer cells lacking KRAS function 10.92
Genome wide miR-191 target profile determined by RIP and gene expression profiling 10.91
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 10.91
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 10.8
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 10.8
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 10.73
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 10.69
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 10.69
An siRNA screen identifies CHD4 as a target for epigenetic therapy 10.68
Gene expression analysis of human liver progenitor-like cells in culture 10.66
Single cell transcriptome of peritoneal cells 10.66
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 10.65
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 10.64
LIN28A modulates splicing and gene expression programs in breast cancer cells 10.64
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 10.64
Systematic discovery of endogenous human ribonucleoprotein complexes 10.57
Transcriptome analysis of human lung epithelial cells 10.53
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 10.5
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 10.44
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.39
Repurposing of promoters and enhancers during mammalian evolution 10.37
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 10.36
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 10.36
RNA-seq of human aneuploid cell lines with Trisomy 21 10.35
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 10.3
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 10.29
Characterization of the Merkel cell carcinoma miRNome 10.26
Transcriptomes in healthy and CHB fetal hearts 10.25
iPSC derived motor neuron cultures from C9ORF72 carriers 10.24
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 10.22
RNA Sequencing of three pairs of gastric cancer 10.2
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 10.2
Ribosomal footprinting of CN34-Parental and CN34-LM1a 10.13
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 10.03
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 10.01
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 9.94
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 9.93
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 9.85
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 9.85
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 9.82
Transcriptomic analysis of the HOTAIR-regulated genes 9.81
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 9.77
Induced DNA demethylation, genome instability and transcription 9.71
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 9.71
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 9.55
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 9.53
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 9.48
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 9.46
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 9.43
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 9.43
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 9.4
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 9.36
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 9.36
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 9.35
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 9.33
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 9.33
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 9.3
Zika infected neural stem cells 9.25
Transcriptome analysis of Zika infected neural stem cells 9.25
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 9.24
Mitochondrial dsRNA triggers antiviral signalling in humans 9.14
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 9.08
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 9.06
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 9.03
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 9.03
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 8.99
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 8.99
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 8.95
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 8.92
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 8.92
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 8.92
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 8.92
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.9
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 8.89
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 8.88
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 8.86
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.77
Regulatory network controlling tumor-promoting inflammation in human cancers 8.66
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 8.66
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 8.62
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 8.61
ARID1A and ARID1B loss in HCT116 and TOV21G cells 8.59
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 8.52
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 8.47
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 8.45
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 8.27
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.26
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 8.24
CD86 regulates a pro-survival signal in myeloma cells 8.23
Differential responses of human fetal brain neural stem cells to Zika virus infection 8.19
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 8.18
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 8.18
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 8.13
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 8.09
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 8.02
Global analyses of the effect of different cellular contexts on microRNA targeting 8.02
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 8.01
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 7.83
p63 controls the enhancer landscape during keratinocyte differentiation 7.72
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 7.71
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 7.69
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 7.68
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 7.66
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 7.66
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 7.64
Differences in miRNA Detection Levels are Technology and Sequence Dependent 7.64
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 7.6
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 7.58
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 7.46
Reprogrammed myeloid cell transcriptomes in NSCLC 7.42
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 7.41
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 7.41
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 7.4
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 7.4
Dynamic 3D chromosomal landscapes in acute leukemia 7.37
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 7.37
FGF2 regulation of gene expression in stable inducible Neurons 7.32
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 7.26
METTL3 and WTAP 7.24
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 7.21
Profiling of escape kinetics of viruses subjected to RNAi 7.2
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 7.11
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 7.0
Total RNA-Seq data from leukemic patients with complex structural variants 6.93
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 6.84
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 6.78
Comparison of microRNA Profiling Platforms (HTS) 6.78
Comparison of microRNA Profiling Platforms 6.78
Genome-wide discovery of human splicing branchpoints 6.74
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 6.72
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 6.66
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 6.66
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 6.65
The transcriptome and chromatin accessbility landscape of mammalian germline 6.65
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.64
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 6.46
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 6.42
The pioneer factor CEBPA modulates vitamin D signaling 6.42
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 6.37
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 6.37
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.36
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 6.3
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 6.22
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 6.14
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 6.07
Gene Expression Profiling of WT and KDM3A Knocked out Cell 6.07
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 6.07
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 6.07
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.02
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 6.01
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 5.98
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 5.98
MARCKS and lnc-MARCKS act as inflammation regulators 5.89
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 5.85
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 5.85
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 5.72
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 5.7
Hepatosplenic T cell lymphoma 5.65
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.65
RNA-seq of RKO cells with cTAZ KO or putback 5.63
Role of microRNAs in the interaction between Salmonella and the host cell 5.57
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.48
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 5.46
The role of the Calcium-Sensing receptor in colorectal cancer 5.44
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 5.43
Argonaute proteins couple chromatin silencing to alternative splicing 5.43
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 5.38
Genome-wide discovery of human splicing branchpoints [RNAse] 5.31
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.3
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 5.27
Changes in human endometrial gland transcriptome over the window of implantation 5.25
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.24
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 5.15
The Glioma-Infiltrating T Cell Receptor Repertoire 5.14
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 5.12
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 5.09
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 5.02
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 4.95
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 4.92
Single-cell analysis of human kidney organoids 4.87
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 4.78
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 4.53
Aortic Valve Tissue: Stenosis vs. Sclerosis 4.48
Measure transcript integrity using RNA-seq data 4.44
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.41
A single-cell transcriptome atlas of the human pancreas 4.4
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 4.23
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 4.15
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.04
Hepatic transcriptome of pediatric hepatoblastoma. 4.01
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 3.96
Activity-dependent transcriptional changes in human neurons 3.94
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 3.89
Molecular Criteria for Defining the Naive Human Pluripotent State 3.85
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 3.84
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 3.77
RNA-seq of naive and primed ES cells 3.7
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 3.66
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.65
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 3.56
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 3.48
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 3.48
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 3.43
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 3.42
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 3.39
Ribosome profiling upon inhibition of eIF4A 3.14
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.09
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 3.01
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 3.01
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.9
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 2.85
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 2.84
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.67
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.66
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.55
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.55
CHCHD10 gene KO effect in iPSC drived motor neurons 2.41
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.4
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.39
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.32
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.32
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.13
Metabolism as an early predictor of DPSCs aging 2.06
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.05
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.93
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.91
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.87
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.86
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.86
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.85
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.84
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.82
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.79
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.79
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.73
The role of m6A/m-RNA methylation in stress response regulation 1.63
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 1.63
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.62
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.61
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.6
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.55
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.52
RNA-sequencing 1.5
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 1.5
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.47
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.46
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 1.38
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 1.29
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.24
Effect of ILF3 on translation during homeostasis and the antiviral response 1.22
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.22
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.21
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.1
In vitro modeling of human germ cell development using pluripotent stem cells 1.07
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.06
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 0.99
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.91
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.91
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.86
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.85
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.83
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.83
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.78
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 0.67
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.66
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.66
CHCHD2 gene KO effect in iPSC drived motor neurons 0.65
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.61
RNA-Seq and expression data from human adipose tissue 0.61
RNAseq of Breast cancer PDX samples 0.58
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.53
Transcriptome-wide response to synthetic chromatin protein PcTF 0.38
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 0.38
SOX11 knockdown in B-ALL cell lines 0.32
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.31
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.3
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.3
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.3
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.21
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.15
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.09
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.03
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.0
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation